We are striving for guarding your health,

Serving every patient with our full heart.

Group News

China Resources Phoenix wins the "Award of China financing listed company in2016 - the most investment value award”

Release time:2017-02-03 Source: Font: big medium small

On January 13, 2017, the “Award of China financing listed company” sponsored by “China Financing” magazine and listed company committee of the Hong Kong Chinese Enterprises Association was held in Hong Kong. As the leader of China's medical service industry, China Resources Phoenix Medical shareholdings Co., Ltd. (stock code: 01515.HK, hereinafter referred to as “China Resources Phoenix”) won the “Award of China financing listed company in2016 - the most investment value award.”

The Award of China financing listed company is dedicated to the selection of outstanding examples of Hong Kong listed companies and their management teams and recognition of their outstanding performance in the business community over the past year. The public and investors can know better the performance of awarded corporation over the past year by this award, so that corporate image and its brand are more deeply rooted, at the same time, specifying a very valuable investment direction for investors.

China Resources Phoenix adheres to the culture of “Caring, Innovation, Perseverance, Sharing”, under the guidance of the highest strategy “benefit all with benevolence and competence”, follows the core values of “take professional responsibility by hard work, hard work creates a happy life”, practices the mission of “provide good quality, reasonable price, safe and accessible medical services”, pursues the visions of “build a world-class medical industry group”. The award “Award of China financing listed company in2016” strongly reflects highly recognized from capital market of the Hong Kong region for China Resources Phoenix Company.

In the future, China Resources Phoenix will actively play its own reform of medical institutions and management advantages, combined with resources of strategic shareholders to speed up in the macro environment of comprehensively deepening medical system reform, expand the scale of medical service network, improve medical quality and further consolidate the leading position of the medical service industry in China.